ATTENUATION OF THE ANTINOCICEPTIVE ACTION OF THE SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST, U-50,488H BY ICS-205-930

被引:20
作者
HO, BY [1 ]
TAKEMORI, AE [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,DEPT PHARMACOL,3-249 MILLARD HALL,435 DELAWARE ST SE,MINNEAPOLIS,MN 55455
关键词
D O I
10.1016/0014-2999(90)90117-O
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The antinociceptive action of s.c. administered U-50,488H was antagonized by s.c. administered ICS-205-930, a selective 5-HT3 receptor antagonist. To characterize the site of interaction, U-50,488H and ICS-205-930 were administered either intracerebroventricularly (i.c.v.) or intrathecally (i.t.). When U-50,488H was administered i.c.v., its antinociception action was antagonized by ICS-205-930 given either i.c.v. or i.t., increasing the ED50 values of U-50,488H by approximately twofold from 48 to 98 and 90 nmol/mouse, respectively. However, when U-50,488H was administered i.t., its antinociception action was not antagonized by ICS-205-930 given either i.c.v. or i.t. These findings suggest that i.c.v., but not i.t. administered U-50,488H may release serotonin both supraspinally and spinally to interact with 5-HT3 receptors to produce antinociception. © 1990.
引用
收藏
页码:371 / 373
页数:3
相关论文
共 10 条
[1]  
CRISP T, 1988, PHARMACOLOGIST, V30, pA153
[2]  
D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
[3]  
FINNEY DJ, 1964, STATISTICAL METHODS
[4]   MONOAMINES AND DESCENDING CONTROL OF NOCICEPTION [J].
FITZGERALD, M .
TRENDS IN NEUROSCIENCES, 1986, 9 (02) :51-52
[5]  
HO BY, 1989, J PHARMACOL EXP THER, V250, P508
[6]  
HO BY, 1989, FASEB J, V3, pA420
[7]   5-HYDROXYTRYPTAMINE RECEPTOR SUBTYPES - MOLECULAR, BIOCHEMICAL AND PHYSIOLOGICAL CHARACTERIZATION [J].
PEROUTKA, SJ .
TRENDS IN NEUROSCIENCES, 1988, 11 (11) :496-500
[8]  
TULUNAY FC, 1974, J PHARMACOL EXP THER, V190, P395
[9]   INVOLVEMENT OF BIOGENIC-AMINES WITH THE MECHANISMS OF NOVEL ANALGESICS [J].
VONVOIGTLANDER, PF ;
LEWIS, RA ;
NEFF, GL ;
TRIEZENBERG, HJ .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1983, 7 (4-6) :651-656
[10]  
VONVOIGTLANDER PF, 1984, J PHARMACOL EXP THER, V231, P270